World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
Pharmaceutical companies with Generics products are changing the marketplace.
07/26/2005
With growing demand for low cost affordable drugs the growth in sales of generics.
Grouped Articles
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02.09.2006
Branded Drugs Settling More Generic Suits
Wall Street Journal 01.17.2006
Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain
Wall Street Journal 01.20.2006
As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future
Wall Street Journal 01.05.2006
Teva to Acquire Ivax, Another Maker of Generic Drugs
New York Times 07.26.2005
Wall Street Journal 07.26.2005
Betting $10 Billion on Generics, Novartis Seeks to Inject Growth
Wall Street Journal 05.04.2006
Selling Generic Drugs by Mail Turns Into Lucrative Business
Wall Street Journal 05.09.2006
Merck Sets Deal That Prices Zocor Below New Generic
Wall Street Journal 06.21.2006
Zocor, Lipitor Feel Pinch from Generics
Wall Street Journal 07.14.2006
More Low-Cost Generics - WSJ.com
Wall Street Journal 10.22.2006
Ranbaxy Unveils Its Ambition To Be a Generics Powerhouse
Wall Street Journal 01.10.2007
For Booming Biotech Firms, A New Threat: Generics
Wall Street Journal 03.14.2007
Pfizer Reports 18% Drop in Profit, Pares Outlook Amid Generics' Effect
Wall Street Journal 04.21.2007
In Trade Deal, a Shift on Generics
Wall Street Journal 05.17.2007
Mylan Is Now Big Generics Player After Deal for Unit of Merck KGaA
Wall Street Journal 05.14.2007
Drug Makers Tighten Their Belts Again
Wall Street Journal 07.27.2007
Wyeth Loses Bout in Fight on a Generic
New York Times 09.08.2007
Maker of Lipitor Digs In to Fight Generic Rival
New York Times 11.03.2007
Wyeth Hit by Generic Competition and Regulatory Setback
New York Times 12.25.2007
Wall Street Journal 02.06.2008
Generic May Test Sanofi, Bristol's Plavix in Europe
Wall Street Journal 05.10.2008
Daiichi Targets Generics to Extend Reach
Wall Street Journal 06.12.2008
Teva to Buy U.S. Generic Rival Barr for $7.46 Billion
Wall Street Journal 07.19.2008
BusinessWeek 09.04.2008
Generic-Drug Firm Actavis May Be Sold
Wall Street Journal 10.17.2008
Outlook Is Cut for U.S. Drug Sales
Wall Street Journal 10.29.2008
Wall Street Journal 11.01.2008
How a Drug Maker Tries to Outwit Generics
Wall Street Journal 11.17.2008
Teva Deal Probe Gets Extension
Wall Street Journal 12.03.2008
Merck Restructuring Puts a Focus on Generic Drugs
New York Times 12.10.2008
FTC Clears Teva Acquisition of Bar
Wall Street Journal 12.20.2008
Pharmacies Fight Tough Battle on Generic Prices
Wall Street Journal 12.22.2008
Firms Prepare for a Fight Over Generic Drugs
Wall Street Journal 03.12.2009
Generic Competition, Charges Hurt Glaxo's Net
Wall Street Journal 04.23.2009
U.K. Issues Recall Of Various Generics
Wall Street Journal 07.03.2009
India Prepares EU Trade Complaint
Wall Street Journal 08.06.2009
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03.06.2012
Deals to Keep Generic Drugs Off Market Get a Court Rebuff
New York Times 07.26.2012
Cost of Brand-Name Prescription Medicines Soaring
New York Times 11.28.2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04.01.2013
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us